ArticleNature communications2021
HIV reprograms host m
Open access · goldAbstract read
In one paragraph
Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.
0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
44 citing papers in PubMed, 67 citations in OpenAlex.
- Hijacking the Host: Post-Translational Modifications as Molecular Switches in HIV Persistence and Immune Evasion.Journal of medical virology · 2026Review
- The m6Am methyltransferase PCIF1 promotes osteogenic differentiation of mesenchymal stem cells through stabilization of Wnt-related transcripts.PLoS biology · 2026Article
- RNA modification-mediated multidimensional crosstalk: a novel perspective on gene expression regulation.Genome biology · 2026Review
- A nanopore-based HIV-1 reference epitranscriptome.Nucleic acids research · 2026Article
- Article
- Impact of NbioRxiv : the preprint server for biology · 2025Article
- KIAA1429-mediated MCellular & molecular biology letters · 2025Article
- The WW domain presents a promising target for the development of PCIF1 agonists in the treatment of glioma.NPJ precision oncology · 2025Article
- SERBP1-PCIF1 complex-controlled m6Am modification in glutamatergic neurons of the primary somatosensory cortex is required for neuropathic pain in mice.Nature communications · 2025Article
- Decoding meLife · 2025Article
- Decoding mbioRxiv : the preprint server for biology · 2025Article
- The epitranscriptional factor PCIF1 orchestrates CD8Nature immunology · 2025Article
- Decoding microbial carcinogenic strategies: ubiquitination and SUMO modification.Frontiers in microbiology · 2025Review
- Cap-specific terminal N6-methyladeonsine methylation of RNA mediated by PCIF1 and possible therapeutic implications.Genes & diseases · 2025Review
- Past, Present, and Future of RNA Modifications in Infectious Disease Research.ACS infectious diseases · 2024Article
- N6-methyladenosine RNA modification promotes Severe Fever with Thrombocytopenia Syndrome Virus infection.PLoS pathogens · 2024Article
- Cap-Specific mCells · 2024Article
- mJournal of dental research · 2024Article
- Regulation of m6Am RNA modification and its implications in human diseases.Journal of molecular cell biology · 2024Review
- Antiviral factors and their counteraction by HIV-1: many uncovered and more to be discovered.Journal of molecular cell biology · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Qiong ZhangDivision of Genetics, Department of Pediatrics, Institute for Genomic Medicine, Program in Immunology, Center for AIDS Research, University of California San Diego School of Medicine, 9500 Gilman Drive, La Jolla, CA, 92093, USA.
Yuqi KangDivision of Genetics, Department of Pediatrics, Institute for Genomic Medicine, Program in Immunology, Center for AIDS Research, University of California San Diego School of Medicine, 9500 Gilman Drive, La Jolla, CA, 92093, USA.
Shaobo WangDivision of Genetics, Department of Pediatrics, Institute for Genomic Medicine, Program in Immunology, Center for AIDS Research, University of California San Diego School of Medicine, 9500 Gilman Drive, La Jolla, CA, 92093, USA.
Gwendolyn Michelle GonzalezEnvironmental Toxicology Graduate Program and Department of Chemistry, University of California, Riverside, CA, 92521, USA.ORCID 0000-0002-9884-6316
Wanyu LiDivision of Genetics, Department of Pediatrics, Institute for Genomic Medicine, Program in Immunology, Center for AIDS Research, University of California San Diego School of Medicine, 9500 Gilman Drive, La Jolla, CA, 92093, USA.
Hui HuiDivision of Genetics, Department of Pediatrics, Institute for Genomic Medicine, Program in Immunology, Center for AIDS Research, University of California San Diego School of Medicine, 9500 Gilman Drive, La Jolla, CA, 92093, USA.
Yinsheng WangEnvironmental Toxicology Graduate Program and Department of Chemistry, University of California, Riverside, CA, 92521, USA.
Tariq M RanaDivision of Genetics, Department of Pediatrics, Institute for Genomic Medicine, Program in Immunology, Center for AIDS Research, University of California San Diego School of Medicine, 9500 Gilman Drive, La Jolla, CA, 92093, USA. trana@ucsd.edu.ORCID 0000-0001-9558-5766
University of California San Diego · USUniversity of California, Riverside · US
Funding
Modeling HIV/AIDS Associated Neurological Disorders with Human Pluripotent CellsDP1DA039562 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI RANA, TARIQ M · 2015 to 2020
$3.9MIdentification and Regulation of RNA Modification by HIV infection and MethamphetamineR01DA046171 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI RANA, TARIQ M · 2018 to 2022
$3.1MIllumina NovaSeq 6000 Sequencing SystemS10OD026929 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JEPSEN, KRISTEN LYNN · 2019 to 2019
$600kRegulation of HIV-1 Replication by Cellular IncRNAsR21AI125103 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI RANA, TARIQ M · 2016 to 2017
$426kNIAID NIH HHS R21 AI125103NIDA NIH HHS DP1 DA039562NIDA NIH HHS R01 DA046171NIH HHS S10 OD026929
Abstract
N
Indexed as
5' Untranslated RegionsAdaptor Proteins, Signal TransducingAdenosineGenome, ViralHIV-1HIV InfectionsHumansMethylationNuclear ProteinsProtein StabilityProteolysisProto-Oncogene MasProto-Oncogene Protein c-ets-1RNARNA, MessengerRNA Stability5' Untranslated RegionsAdaptor Proteins, Signal TransducingAdenosineETS1 protein, humanMAS1 protein, humanN(6),O(2)-dimethyladenosineNuclear ProteinsPCIF1 protein, humanProto-Oncogene MasProto-Oncogene Protein c-ets-1RNARNA, MessengerRNA, Viralvpr Gene Products, Human Immunodeficiency Virus
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.